Upstream Bio, Inc.
UPB
$17.63
-$0.11-0.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 83.73% | -11.56% | 36.22% | -2.25% | -22.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.73% | -11.56% | 36.22% | -2.25% | -22.08% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 83.73% | -11.56% | 36.22% | -2.25% | -22.08% |
| SG&A Expenses | 86.36% | 71.18% | 59.89% | 83.28% | 51.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 150.88% | 108.13% | 82.21% | 94.86% | 103.87% |
| Operating Income | -152.83% | -113.24% | -83.66% | -101.29% | -113.93% |
| Income Before Tax | -172.29% | -150.32% | -79.51% | -415.54% | -424.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -172.29% | -150.32% | -79.51% | -415.54% | -424.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -172.29% | -150.32% | -79.51% | -415.54% | -424.03% |
| EBIT | -152.83% | -113.24% | -83.66% | -101.29% | -113.93% |
| EBITDA | -152.78% | -113.13% | -83.49% | -101.50% | -114.15% |
| EPS Basic | 88.57% | 89.13% | 90.52% | -229.20% | -113.99% |
| Normalized Basic EPS | 84.77% | 86.01% | 88.29% | -404.52% | -387.76% |
| EPS Diluted | 88.57% | 89.13% | 90.52% | -229.20% | -113.99% |
| Normalized Diluted EPS | 84.77% | 86.01% | 88.29% | -404.52% | -387.76% |
| Average Basic Shares Outstanding | 1,687.12% | 1,689.88% | 1,433.30% | 2.18% | 7.43% |
| Average Diluted Shares Outstanding | 1,687.12% | 1,689.88% | 1,433.30% | 2.18% | 7.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |